Welcome to the upgraded MacSphere! We're putting the finishing touches on it; if you notice anything amiss, email macsphere@mcmaster.ca

Prevention of Venous Thromboembolism in 2020 and Beyond

Thumbnail Image

Files

Prevention of Venous Thromboembolism in 2020 and Beyond.pdf (732.91 KB)

Date

2020-08-01

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

MDPI AG

Abstract

<jats:p>Venous thromboembolism (VTE) is the third most common cause of vascular mortality worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In this review, we discuss how an understanding of VTE epidemiology and the results of thromboprophylaxis trials have shaped the current approach to VTE prevention. We will discuss modern thromboprophylaxis as it pertains to genetic risk factors, exogenous hormonal therapies, pregnancy, surgery, medical hospitalization, cancer, and what is known thus far about VTE in COVID-19 infection.</jats:p>

Description

Keywords

COVID, DVT, PE, VTE, cancer, epidemiology, prevention, prophylaxis

Citation

URI

http://hdl.handle.net/11375/26512

Collections

Faculty Publications (via McMaster Experts)

Endorsement

Review

Supplemented By

Referenced By

Creative Commons license

Attribution - CC BY This Creative Commons license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. Recommended for maximum dissemination and use of licensed materials.
Except where otherwised noted, this item's license is described as Attribution - CC BY This Creative Commons license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. Recommended for maximum dissemination and use of licensed materials.